Chih-Hsin Lee
Overview
Explore the profile of Chih-Hsin Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
716
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lu D, Chang C, Cheng S, Kang E, Lee C, Chen K
Crit Care
. 2024 Feb;
28(1):55.
PMID: 38378580
No abstract available.
12.
Cheng Y, Lee C, Wang S, Chou C, Yang Y, Kao C, et al.
Mol Cell Proteomics
. 2023 Dec;
23(2):100710.
PMID: 38154690
Antibody glycosylation plays a crucial role in the humoral immune response by regulating effector functions and influencing the binding affinity to immune cell receptors. Previous studies have focused mainly on...
13.
Wang J, Pao J, Lee C, Wang J, Lee M, Wu T
PLoS One
. 2023 Dec;
18(12):e0289172.
PMID: 38127940
Background: Olfactory dysfunction is a common manifestation in COVID-19 patients and can significantly impact their quality of life. Corticosteroids have been proposed as a potential treatment, but their efficacy remains...
14.
Lu D, Ou T, Kang J, Ong J, Chen I, Lee C, et al.
J Microbiol Immunol Infect
. 2023 Nov;
57(1):38-47.
PMID: 37951803
Background: Immunomodulatory agents, such as tocilizumab (TCZ), exert promising effects against SARS-CoV-2 infection. However, growing evidence indicates that using TCZ may carry higher risks of secondary bloodstream infection (sBSI). This...
15.
Ju K, Lee R, Lin H, Chen J, Hsu B, Wang J, et al.
J Formos Med Assoc
. 2023 Jun;
122(12):1255-1264.
PMID: 37268474
Background: Fluoroquinolones, crucial components of treatment regimens for drug-resistant tuberculosis (TB), are associated with QT interval prolongation and risks of fatal cardiac arrhythmias. However, few studies have explored dynamic changes...
16.
Putri D, Huang C, Ou T, Lin C, Lee M, Hung C, et al.
J Infect
. 2023 Feb;
86(5):486-488.
PMID: 36822411
No abstract available.
17.
Lee M, Fujita Y, Muraki S, Huang H, Lee C, Wang J, et al.
Br J Clin Pharmacol
. 2022 Sep;
89(2):714-726.
PMID: 36100960
Aim: A population pharmacokinetic (PPK) study of the correlation of adverse drug reactions (ADRs) with the 3HP regimen (weekly high-dose rifapentine plus isoniazid for 12 doses) for latent tuberculosis infection...
18.
Nucleic acid amplification tests reduce delayed diagnosis and misdiagnosis of pulmonary tuberculosis
Feng J, Lin C, Wang J, Chien S, Lin C, Huang W, et al.
Sci Rep
. 2022 Jul;
12(1):12064.
PMID: 35835940
The clinical impact of nucleic acid amplification (NAA) tests on reducing delayed diagnosis and misdiagnosis of pulmonary TB (PTB) has rarely been investigated. PTB patients were classified into a frontline...
19.
Chen J, Lee C, Lee M, Huang P, Yen T, Lee M, et al.
J Clin Pharmacol
. 2022 Jun;
62(11):1412-1418.
PMID: 35644012
Bisphosphonates are considered an effective inhibitor of glutamine synthetase and thus can be used for treating tuberculosis (TB). However, its clinical benefit in TB remains unknown. We conducted a population-based...
20.
Peng T, Chen J, Chang Y, Shiang J, Lee M, Lee C, et al.
J Glob Antimicrob Resist
. 2022 May;
29:378-385.
PMID: 35533986
Objectives: We conducted an updated network meta-analysis to elucidate the best regimen for latent tuberculosis infection (LTBI). Methods: We searched the PubMed, Embase, and Cochrane Library databases on 16 August...